Haleon PLC (GB:HLN) has released an update.
Haleon PLC has announced that Pfizer Inc. has significantly reduced its holdings in the company by selling a total of 700,526,315 ordinary shares, including both a secondary offering and an off-market transaction. This sale changes Pfizer’s voting rights in Haleon from 22.58% to 15.04%, based on Haleon’s total issued voting share capital. The transaction, completed on October 3rd, 2024, reflects a notable shift in Haleon’s shareholder structure.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
